These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 29162351)

  • 1. Refining the Assessment and Implications of AR-V7 in Castrate-resistant Prostate Cancer.
    Crumbaker M; Savdie R; Joshua AM
    Eur Urol; 2018 May; 73(5):736-737. PubMed ID: 29162351
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer: Exosomal AR-V7 is a marker of hormonal therapy resistance.
    Fenner A
    Nat Rev Urol; 2016 Dec; 13(12):695. PubMed ID: 27779227
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker with Outcomes and Survival in Castration-Resistant Prostate Cancer.
    Taneja SS
    J Urol; 2016 Oct; 196(4):1124. PubMed ID: 27628794
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen receptor variant-7: an important predictive biomarker in castrate resistant prostate cancer.
    Sartor O; Dong Y
    Asian J Androl; 2015; 17(3):439-40. PubMed ID: 25532583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate.
    Todenhöfer T; Azad A; Stewart C; Gao J; Eigl BJ; Gleave ME; Joshua AM; Black PC; Chi KN
    J Urol; 2017 Jan; 197(1):135-142. PubMed ID: 27436429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression.
    Tommasi S; Pilato B; Carella C; Lasorella A; Danza K; Vallini I; De Summa S; Naglieri E
    Prostate; 2019 Jan; 79(1):54-61. PubMed ID: 30141201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
    Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z
    Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HoxB13 mediates AR-V7 activity in prostate cancer.
    Navarro HI; Goldstein AS
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6528-6529. PubMed ID: 29891672
    [No Abstract]   [Full Text] [Related]  

  • 10. Has the PROPHECY of AR-V7 Been Fulfilled?
    De Laere B; Ost P; Grönberg H; Lindberg J
    J Clin Oncol; 2019 Aug; 37(24):2181-2182. PubMed ID: 31265360
    [No Abstract]   [Full Text] [Related]  

  • 11. AR-V7 detection guides treatment.
    Romero D
    Nat Rev Clin Oncol; 2018 Sep; 15(9):533. PubMed ID: 30018408
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.
    Scher HI; Graf RP; Schreiber NA; McLaughlin B; Lu D; Louw J; Danila DC; Dugan L; Johnson A; Heller G; Fleisher M; Dittamore R
    Eur Urol; 2017 Jun; 71(6):874-882. PubMed ID: 27979426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer.
    Saylor PJ; Lee RJ; Arora KS; Deshpande V; Hu R; Olivier K; Meneely E; Rivera MN; Ting DT; Wu CL; Miyamoto DT
    Clin Cancer Res; 2017 Jan; 23(2):363-369. PubMed ID: 27440270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells.
    Nakata D; Koyama R; Nakayama K; Kitazawa S; Watanabe T; Hara T
    Prostate; 2017 Jun; 77(9):955-961. PubMed ID: 28397338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.
    Kohli M; Ho Y; Hillman DW; Van Etten JL; Henzler C; Yang R; Sperger JM; Li Y; Tseng E; Hon T; Clark T; Tan W; Carlson RE; Wang L; Sicotte H; Thai H; Jimenez R; Huang H; Vedell PT; Eckloff BW; Quevedo JF; Pitot HC; Costello BA; Jen J; Wieben ED; Silverstein KAT; Lang JM; Wang L; Dehm SM
    Clin Cancer Res; 2017 Aug; 23(16):4704-4715. PubMed ID: 28473535
    [No Abstract]   [Full Text] [Related]  

  • 18. Calpain and AR-V7: Two potential therapeutic targets to overcome acquired docetaxel resistance in castration-resistant prostate cancer cells.
    Liu L; Lou N; Li X; Xu G; Ruan H; Xiao W; Qiu B; Bao L; Yuan C; Huang X; Wang K; Cao Q; Chen K; Yang H; Zhang X
    Oncol Rep; 2017 Jun; 37(6):3651-3659. PubMed ID: 28498452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical decision-making with AR-V7.
    Thoma C
    Nat Rev Urol; 2019 Dec; 16(12):694. PubMed ID: 31690843
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
    Atala A
    J Urol; 2019 Nov; 202(5):869-870. PubMed ID: 31365309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.